US Patent 7834043 HIV protease inhibiting compounds
Patent 7834043 was granted and assigned to Abbott on November, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+40 characters)
Article
Patent abstract
A compound of the formula
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Infobox
Patent Inventor Names
Charles A. Flentge0
Dale J. Kempf0
David A. DeGoey0
David J. Grampovnik0
John T. Randolph0
Larry L. Klein0
Ming C. Yeung0
Su Yu0
William J. Flosi0
Xiu C. Wang0
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07834043 HIV protease inhibiting compounds US Patent 7834043 HIV protease inhibiting compounds
Infobox
Patent Number
078340430
Patent Number
78340430
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078340430
Date of Patent
November 16, 2010
0Patent Application Number
110087130
Date Filed
December 9, 2004
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07834043 HIV protease inhibiting compounds
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07834043
Date of patent
November 16, 2010
Patent application number
11008713
Date Filed
December 9, 2004
Patent primary examiner
Find more entities like US Patent 7834043 HIV protease inhibiting compounds
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
